Eagle Pharmaceuticals, Inc. Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements
Eagle Pharmaceuticals, Inc. reported Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements of 63.75 thousand shares for the 3-month period ending 2023-06-30, per its 10-Q/A filed 2023-08-09.
Discontinued › Notes
us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements · last filed 2023-08-09
- Eagle Pharmaceuticals, Inc. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2023-06-30 was 63.75K shares.
- Eagle Pharmaceuticals, Inc. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2023-03-31 was 94.12K shares, a 52.02% decline year-over-year.
- Eagle Pharmaceuticals, Inc. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2022-09-30 was 0.00 shares.
- Eagle Pharmaceuticals, Inc. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2022-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- Eagle Pharmaceuticals, Inc. incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2022 was 131.60K shares.
- Eagle Pharmaceuticals, Inc. incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2021 was 0.00 shares, a 100.00% decline from fiscal 2020.
- Eagle Pharmaceuticals, Inc. incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2020 was 289.87K shares, a 24.56% decline from fiscal 2019.
- Eagle Pharmaceuticals, Inc. incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2019 was 384.22K shares, a 24.67% decline from fiscal 2018.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 3 month | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 6 month | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 9 month | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 12 month |
|---|---|---|---|---|
| 2023-06-30 | 63.75K shares 10-Q/A · filed 2023-08-09 | 76.02K shares 10-Q/A · filed 2023-08-09 | ||
| 2023-03-31 | 94.12K shares 10-Q · filed 2023-05-09 | |||
| 2022-12-31 | 131.60K shares 10-K · filed 2023-03-23 | |||
| 2022-09-30 | 0.00 shares 10-Q · filed 2022-11-09 | 145.08K shares 10-Q · filed 2022-11-09 | ||
| 2022-06-30 | 0.00 shares 10-Q/A · filed 2023-08-09 | 178.06K shares 10-Q/A · filed 2023-08-09 | ||
| 2022-03-31 | 196.16K shares 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | 0.00 shares 10-K · filed 2023-03-23 | |||
| 2021-09-30 | 0.00 shares 10-Q · filed 2022-11-09 | 0.00 shares 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | 153.17K shares 10-Q · filed 2022-08-09 | 177.55K shares 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | 0.00 shares 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | 289.87K shares 10-K · filed 2023-03-23 | |||
| 2019-12-31 | 384.22K shares 10-K · filed 2022-03-08 | |||
| 2018-12-31 | 510.03K shares 10-K · filed 2021-03-05 | |||
| 2017-12-31 | 805.32K shares 10-K · filed 2020-03-02 | |||
| 2016-12-31 | 900.42K shares 10-K · filed 2019-02-28 | |||
| 2015-12-31 | 1.00M shares 10-K · filed 2018-02-26 | |||
| 2014-12-31 | 0.00 shares 10-K · filed 2017-03-15 | |||
| 2014-09-30 | 0.00 shares 10-K · filed 2017-03-15 | |||
| 2013-09-30 | 0.00 shares 10-K · filed 2016-02-29 |